Pipeline
Program
Therapeutic Approach
Discovery
Lead Optimization
IND Enabling
Phase 1
Sovilnesib
(KIF18A inhibitor)
(KIF18A inhibitor)
Synthetic Lethal
Phase 1
VLS-1488
(KIF18A inhibitor)
(KIF18A inhibitor)
Synthetic Lethal
IND Enabling
Nondisclosed Targets
Synthetic Lethal
Discovery
New Target Discovery
Immune Activation
Discovery